| William D. Barbo |
William D. Barbo is currently the Chief Commercial Officer & Executive VP at Charles River Laboratories International, Inc. He started this position in 2016. In terms of education, Mr. Barbo completed his undergraduate degree at Boston College. He then went on to earn an MBA from Northeastern University. He also obtained a graduate degree from the University of Massachusetts. |
| John C. Ho |
John C. Ho is currently the Chief Strategy Officer & SVP-Corporate Strategy at Charles River Laboratories International, Inc. He previously held positions as Senior Vice President-Corporate Strategy at the same company, Director at Frequency Electronics, Inc., Partner at McKinsey & Co., Inc., PRTM Management Consultants LLC, and Accenture (California). Dr. Ho has an undergraduate degree from Massachusetts Institute of Technology, an MBA from Tuck School of Business at Dartmouth, and a doctorate from The Warren Alpert Medical School. |
| Birgit Girshick |
Birgit Girshick is currently the Chairman at CRL Group France SAS and the Director at Charles River Discovery Research Services UK Ltd., Charles River Discovery Research Services Finland Oy, KWS BioTest Ltd., Argenta Discovery 2009 Ltd., and BioFocus DPI (Holdings) Ltd. She previously served as the Chief Operating Officer & Executive Vice President at Charles River Laboratories International, Inc. Ms. Girshick holds an MBA from the University of Rhode Island, which she obtained in 2002, and an undergraduate degree from Eastern Connecticut State University, which she received in 2000. |
| Matthew L. Daniel |
Matthew L. Daniel is currently working as the Secretary, Chief Compliance Officer & Senior VP at Charles River Laboratories International, Inc. He previously worked as an Attorney at Goodwin Procter LLP from 2000 to 2005. Mr. Daniel completed his undergraduate degree at Cornell University in 1992 and his graduate degree at New York University School of Law in 1995. |
| Gina M. Mullane |
Gina M. Mullane is currently the Chief Marketing Officer & Senior Vice President at Charles River Laboratories International, Inc. She holds an MBA from Bentley University and an undergraduate degree from the University of New Hampshire. |
| Shannon M. Parisotto |
Shannon M. Parisotto is currently the Senior VP-Global Operations & Controller at Charles River Laboratories International, Inc. She completed her undergraduate degree at the University of Nevada in 1996 and earned an MBA from the University of Phoenix. |
| James C. Foster |
James C. Foster is currently the Chairman, President & Chief Executive Officer at Charles River Laboratories International, Inc. He is also the Chairman, President & Chief Executive Officer at Charles River Laboratories, Inc. Additionally, he serves as the Executive Director at MIT Sloan School of Management and as a Member of both the American Bar Association and the Massachusetts Bar Association. He is also an Advisor at Longwood Fund Management LLC. In the past, Mr. Foster has held positions such as Chairman at the Institute of Contemporary Art, Director at BioTransplant, Inc., and Director at Cell Signaling Technology, Inc. He has also served as a Director at Titterington's Olde English Bake Shop, Ltd. and as the Manager-Private Money at RiverSource Investments LLC. Furthermore, he has worked as a Vice President at Smith Barney, Inc. and as the President, General Counsel & VP-Administration at Charles River Biotechnical Services, Inc.Mr. Foster has a graduate degree from the Massachusetts Institute of Technology, an undergraduate degree from Lake Forest College, and a graduate degree from Boston University School of Law. |
| Julie Frearson |
Julie Frearson is currently the Chief Scientific Officer & Senior Vice President at Charles River Laboratories International, Inc. She previously worked as the Director at Scottish Universities Life Sciences Alliance. Dr. Frearson obtained a doctorate degree from King's College London. |
| Mark Mintz |
Mark Mintz is currently the Chief Information Officer & Senior Vice President at Charles River Laboratories International, Inc. He completed his undergraduate degree at the State University of New York at Albany. |
| Flavia H. Pease |
Flavia H. Pease is an Independent Director at Insulet Corp. and the Chief Financial Officer & Executive Vice President at Charles River Laboratories International, Inc. She previously worked at Johnson & Johnson as the Group CFO-Global Medical Devices Business. Ms. Pease holds an MBA from Santa Clara University and an undergraduate degree from PontifÃcia Universidade Católica do Rio de Janeiro. |
| Michael Gunnar Knell |
Michael Gunnar Knell is currently the Chief Accounting Officer & Senior Vice President at Charles River Laboratories International, Inc. and the Chief Accounting Officer at Bruker Daltonics, Inc. He previously worked as a Partner at Ernst & Young LLP from 1998 to 2011, as the Chief Accounting Officer & Vice President-Finance at Bruker Corp. from 2012 to 2017, and as Treasurer at Bruker Detection Corp. He received his undergraduate degree from the State University of New York at Buffalo in 1998. |
| Victoria L. Creamer |
Victoria L. Creamer is currently the Chief People Officer & Executive Vice President at Charles River Laboratories International, Inc. She previously worked at International Business Machines Corp. as Vice President-Global Compensation & Recognition from 1991 to 2015. She also worked at ITT Corp. as Senior Vice President-Human Resources. From 2015 to 2019, she worked at ITT, Inc. as Senior VP-Human Resources & Communications. Ms. Creamer has an undergraduate degree from Hartwick College and a graduate degree from Fordham University. |
| Barbara J. Patterson |
Barbara J. Patterson is currently the Senior VP-Regulatory Affairs & Compliance at Charles River Laboratories International, Inc. She previously worked as the Senior Director-Regulatory Compliance at Primedica Corp. She obtained an undergraduate degree from The Pennsylvania State University. |
| George Llado |
George Llado is an Independent Director at Charles River Laboratories International, Inc. and a Director at both the National Center for Women & Information Technology and TraceLink, Inc. He previously held the position of Vice President-Manufacturing Operations at Merck & Co., Inc. and was the Chief Information Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. |
| Nancy C. Andrews |
Nancy C. Andrews is currently serving as the Chairman of the American Academy of Arts & Sciences. She is also an Independent Director at Charles River Laboratories International, Inc., a Director at Charles River Laboratories, Inc., and a Director at Novartis International AG. Additionally, she holds the position of Independent Non-Executive Director at Novartis AG since 2015. Dr. Andrews is also a Director at Maze Therapeutics, Inc. and the Chief Scientific Officer & Executive VP at The Children's Hospital Corp. She is a Council Member at the National Academy of Sciences and a Member of the National Academy of Medicine (United States) since 2019. Furthermore, she serves as a Member of the Scientific Management Review Board and the MIT Corp. (United States). In her former roles, Dr. Andrews served as the Chairman of The Burroughs Wellcome Fund from 2011 to 2019. She was also a Director at Duke University Health System, Inc. and a Program Director at Harvard Mit Health Sciences & Technology from 1999 to 2003. Dr. Andrews held the position of Professor at Duke University from 2007 to 2021 and was a Member-Scientific Management Review Board at the National Institutes of Health from 2014 to 2019. She served as the President of the American Society for Clinical Investigation and was the Dean of Harvard Medical School from 2003 to 2007. Additionally, she was the Dean-Emerita & Vice Chancellor-Emerita at Duke University School of Medicine from 2017 to 2021. Dr. Andrews obtained a doctorate degree from the Massachusetts Institute of Technology and Yale University. She also holds undergraduate and graduate degrees from Yale University. Furthermore, she earned a doctorate degree from Harvard Medical School. |
| George E. Massaro |
George E. Massaro is currently the Lead Independent Director at Charles River Laboratories International, Inc. and an Independent Director at Charles River Laboratories, Inc. Previously, he served as the Vice Chairman at Huron Consulting Group, Inc. from 2010 to 2020. He was also a Director at Eastern Bank Corp. from 2003 to 2017 and the Managing Partner at Arthur Andersen LLP from 1998 to 2002. Additionally, he held the position of Trustee at Mount Auburn Hospital from 2013 to 2017 and was the Chief Operating Officer at Huron Consulting Services LLC from 2002 to 2005. Mr. Massaro holds an MBA from Babson College and an undergraduate degree from Bentley University. |
| Virginia M. Wilson |
Virginia M. Wilson is an Independent Director at Charles River Laboratories International, Inc., and Carrier Global Corp. She is also the Chief Financial Officer, Executive VP & Manager at Redwood Holdings LLC, and Executive Vice President at TIAA-CREF Asset Management LLC and TIAA Asset Management Finance Co. LLC. She has also worked as an Audit Partner at Deloitte & Touche LLP. Ms. Wilson holds an undergraduate and graduate degree from the University of Illinois. |
| Robert J. Bertolini |
Robert J. Bertolini is an Independent Director at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc. He was previously an Independent Director at Bristol Myers Squibb Co., a Director at Genzyme Corp., an Independent Non-Executive Director at Actelion Ltd., a Director at Physicians World Communications Group, a Director at New Jersey Performing Arts Center Corp., a Director at electroCore, Inc., a Director at Actelion Pharmaceuticals Ltd., and a Non-Executive Director at Idorsia Ltd. He was also the President & Chief Financial Officer at Bausch & Lomb, Inc. and the Chief Financial Officer & Executive Vice President at Schering-Plough Corp. Prior to that, he was a Partner at PricewaterhouseCoopers LLP. He received his undergraduate degree from Rutgers State University of New Jersey. Currently, he holds the position of Independent Director at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc. |
| Deborah Turner Kochevar |
Deborah Turner Kochevar is an Independent Director at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc. She is also an Independent Director at Elanco Animal Health, Inc. and holds the position of Senior Vice President at Tufts University. In her former roles, she served as Chairman-Education Council at the American Veterinary Medical Association, President-Veterinary Clinical Pharmacology at The American College of Financial Services, and President at the Association of American Veterinary Medical College. She was also a Member at the College of Veterinary Medicine & Biomedical Sciences. From 2006 to 2018, she served as the Dean of Cummings School of Veterinary Medicine. Dr. Kochevar completed her undergraduate degree at Rice University and obtained doctorate degrees from Texas A&M University, The American College of Financial Services, and The University of Texas Southwestern Medical Center. |
| Richard F. Wallman |
Richard F. Wallman is an Independent Director at CECO Environmental Corp., Roper Technologies, Inc., and Charles River Laboratories International, Inc. He is also a Director at SmileDirectClub LLC and a former Independent Director at Convergys Corp., Ariba, Inc., and. Extended Stay America, Inc. Wallman has also held various Director positions at Bausch & Lomb, Inc., Rural, Lear Corp., Maxion Wheels, Avaya, Inc., ExpressJet Holdings LLC, Bausch & Lomb Holdings, Inc., ESH Hospitality, Inc., Boart Longyear Ltd., Tornier NV, and Dana, Inc. He was the Chief Financial Officer & Senior Vice President at AlliedSignal, Inc. and the Vice President & Controller at International Business Machines Corp. Wallman holds an undergraduate degree from Vanderbilt University and an MBA degree from The University of Chicago Booth School of Business. Wallman's current jobs are Independent Director at CECO Environmental Corp., Roper Technologies, Inc., Charles River Laboratories International, Inc., and SmileDirectClub, Inc. |
| Martin W. MacKay |
Martin W. MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018. He is also the Executive Chairman at Rallybio Corp., founded in 2018. In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd. (Ireland) and Rallybio Holdings LLC. He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018. Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp. Ltd., Neverfail, Inc., and Neverfail Ltd. He was also a Director at Encysive Pharmaceuticals, Inc. in 2008. Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp. and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp. from 2020 to 2022. He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013. From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd. (United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK). Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979. |
| Craig B. Thompson |
Craig B. Thompson is the founder of Agios Pharmaceuticals, Inc. (founded in 2007). He is currently the President, Chief Executive Officer & Trustee at Memorial Sloan Kettering Cancer Center, President, Chief Executive Officer & Director at Memorial Sloan-Kettering Cancer Center (Investment Management), Director at Regeneron Pharmaceuticals, Inc., Independent Director at Charles River Laboratories International, Inc., and Director at Howard Hughes Medical Institute, Inc., The University of Texas M.D. Anderson Cancer Center, American Association for Cancer Research, New York Genome Center, Ohio State University Comprehensive Cancer Center, City of Hope Comprehensive Cancer Center, National Academy of Sciences, The Economic Club of New York, American Academy of Arts & Sciences, National Academy of Medicine (United States), Association of American Physicians, American Society for Clinical Investigation, and American Association of Physicists In Medicine. He has previously served as President & Chief Executive Officer at The Society of Memorial Sloan-Kettering Cancer Center, Independent Director at Merck & Co., Inc. (2008-2018), Director at Schering-Plough Corp. (2008-2009), Independent Director at Charles River Laboratories International, Inc. (2013-2018), Director at Charles River Laboratories, Inc., Director at Abramson Cancer Center (2010), Professor at the University of Pennsylvania (1999-2011), Associate Vice President-Cancer Services at The University of Pennsylvania Health System (2006-2010), Professor at the University of Michigan (1987-1993), Professor at Uniformed Services University of the Health Sciences (1982-1987), and Professor at Perelman School of Medicine (1999-2011). He has an undergraduate degree from Dartmouth College and a doctorate degree from the University of Pennsylvania. |
| Reshema Kemps-Polanco |
Reshema Kemps-Polanco is currently working as the Chief Commercial Officer & Executive VP at Novartis Corp. Prior to her current role, she worked as an Independent Director at Charles River Laboratories International, Inc. |
